ArticleMedical oncology (Northwood, London, England)2020

c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation.

Guoqun Jia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.